Detalhe da pesquisa
1.
A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20).
Jpn J Clin Oncol
; 52(10): 1225-1231, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809896
2.
Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial.
Cancer Sci
; 111(12): 4540-4547, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010107
3.
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core-binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Pediatr Blood Cancer
; 67(12): e28692, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886449
4.
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Pediatr Blood Cancer
; 65(12): e27368, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30084127
5.
Evaluation of high-dose cytarabine in induction therapy for children with de novo acute myeloid leukemia: a study protocol of the Japan Children's Cancer Group Multi-Center Seamless Phase II-III Randomized Trial (JPLSG AML-12).
Jpn J Clin Oncol
; 48(6): 587-593, 2018 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29889285
6.
Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
J Pediatr Hematol Oncol
; 40(1): e34-e37, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28538509
7.
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Pediatr Blood Cancer
; 63(8): 1394-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135782
8.
Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Pediatr Blood Cancer
; 63(3): 451-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26585702
9.
Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Pediatr Blood Cancer
; 62(7): 1294-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25790170
10.
Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome.
Blood
; 120(9): 1810-5, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22776818
11.
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.
Int J Hematol
; 113(3): 395-403, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230647
12.
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
Haematologica
; 99(11): e225-7, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25015941
13.
Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
Int J Hematol
; 107(5): 586-595, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330746
14.
Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.
Int J Hematol
; 107(2): 201-210, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29027108
15.
Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Int J Hematol
; 98(5): 578-88, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24068655